PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
05-Apr-2024 EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials EnteroBiotix
03-Apr-2024 Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC Nxera Pharma
03-Apr-2024 Agilent and UC San Diego Launch Center of Excellence in Cellular Intelligence Agilent Technologies
03-Apr-2024 Precision Oncology Innovator SimBioSys and General Inception Announce Strategic Partnership to Accelerate Cancer Drug Development SimBioSys, Inc.
03-Apr-2024 EnteroBiotix Initiates Phase 2 Study of EBX-102-02 in Patients with Irritable Bowel Syndrome (IBS) EnteroBiotix Limited
03-Apr-2024 Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio Genmab A/S
03-Apr-2024 Lindus Health Unveils Versatile “All-in-One Respiratory CRO” Offering Tailored to Respiratory Clinical Trials Lindus Health
02-Apr-2024 Cisiv bolsters leadership team with appointment of Chief Delivery Officer Cisiv
01-Apr-2024 Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection Creative Diagnostics
01-Apr-2024 Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development Creative Diagnostics
01-Apr-2024 Creative Diagnostics Announces Comprehensive Vomitoxin Test Reagents for Food Safety Applications Creative Diagnostics
01-Apr-2024 STEMart Announces Pilot Production Services for Medical Devices STEMart
31-Mar-2024 Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study Avance Clinical
28-Mar-2024 Elekta partners with MSD to enhance kidney cancer care using digital solutions Elekta
28-Mar-2024 Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development Intravacc and Primrose Bio
28-Mar-2024 NOVEL PSYCHEDELIC COMPOUND TO BE TESTED FOR TREATMENT OF ALCOHOL USE DISORDER Clerkenwell Health
28-Mar-2024 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Patients with Locally Advanced or Metastatic MET Exon 14 NSCLC HUTCHMED
28-Mar-2024 Corteria Pharmaceuticals announces initiation of Phase 1 study to evaluate CRF2 agonist COR-1167 for treatment of worsening heart failure Corteria Pharmaceuticals
27-Mar-2024 Top Eight Reasons to Attend Semantic Data 2024:  Taxonomy, Ontology, and Knowledge Graphs Conference  Henry Stewart
27-Mar-2024 11th Edition Human Factors and User Experience for Medical Device Design Conference Set to Equip Industry Leaders with Innovative Strategies marcus evans